Phase Ill Trial Of Metronomic Capecitabine Maintenance After Standard Treatment In Operable Triple-Negative Breast Cancer (Sysucc-001).
JOURNAL OF CLINICAL ONCOLOGY(2020)
Abstract
507Background: Triple-negative breast cancer (TNBC) has a relatively high relapse rate and poor outcome after standard therapy among all subtypes of breast cancer. Effective strategies to reduce ri...
MoreTranslated text
Key words
metronomic capecitabine maintenance,breast cancer,triple-negative
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined